NASDAQ:HTGMQ HTG Molecular Diagnostics (HTGMQ) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HTGMQ Stock Alerts $0.0025 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.0015▼$0.002550-Day Range N/A52-Week Range$0.00▼$3.24Volume1,835 shsAverage Volume1,255 shsMarket Capitalization$5,525.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial Media Get HTG Molecular Diagnostics alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About HTG Molecular DiagnosticsHTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More HTGMQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HTGMQ Stock News HeadlinesFebruary 24, 2024 | finance.yahoo.comCancer Molecular Diagnostics Market Sees Robust Growth; New Report Details Forecasts and Trends through 2027See More Headlines Receive HTGMQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:HTGMQ CUSIPN/A CIK1169987 Webwww.htgmolecular.com Phone877-289-2615Fax520-547-2837Employees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.37 million Price / Sales0.00 Cash Flow$0.25 per share Price / Cash Flow0.01 Book Value$2.44 per share Price / Book0.00Miscellaneous Outstanding Shares2,210,000Free Float2,156,000Market Cap$5,525.00 OptionableNot Optionable Beta2.97 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. John L. Lubniewski (Age 60)President, CEO & Director Comp: $821.19kMr. Shaun D. McMeans (Age 62)Senior VP, CFO, Secretary & Treasurer Comp: $533.97kMs. Laura Lee Godlewski (Age 44)Senior Vice President of Finance & Administration Dr. Debra A. Gordon (Age 64)Senior VP & Chief Legal Counsel Comp: $219.47kDr. Patrick C. Roche (Age 71)Senior Vice President of Research & Development Comp: $257.58kDr. Stephen A. Barat Ph.D. (Age 54)Senior Vice President of Therapeutics Dr. Christina M. Carruthers Ph.D.Vice President of Target Strategy & Early DevelopmentDebrah ThompsonVice President of Scientific InnovationMore ExecutivesKey CompetitorsGenocea BiosciencesNASDAQ:GNCAQGenocea BiosciencesNASDAQ:GNCAKaleido BiosciencesNASDAQ:KLDOViveve MedicalNASDAQ:VIVEAllied Healthcare ProductsNASDAQ:AHPIView All Competitors HTGMQ Stock Analysis - Frequently Asked Questions How have HTGMQ shares performed in 2024? HTG Molecular Diagnostics' stock was trading at $0.0013 at the beginning of 2024. Since then, HTGMQ shares have increased by 92.3% and is now trading at $0.0025. View the best growth stocks for 2024 here. How do I buy shares of HTG Molecular Diagnostics? Shares of HTGMQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HTGMQ) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HTG Molecular Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
